| Nome |
# |
|
Non-coding RNAs functioning in colorectal cancer stem cells, file e3ad891a-bb09-da0e-e053-3705fe0a2b96
|
1.690
|
|
Involvement of non-coding RNAs in chemo- and radioresistance of colorectal cancer, file e3ad891a-fee4-da0e-e053-3705fe0a2b96
|
1.674
|
|
Effects of Dietary Restriction on Cancer Development and Progression, file e3ad891b-d1f5-da0e-e053-3705fe0a2b96
|
816
|
|
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone?, file e3ad891d-4881-da0e-e053-3705fe0a2b96
|
548
|
|
Dietary restriction: could it be considered as speed bump on tumor progression road?, file e3ad8919-0b8f-da0e-e053-3705fe0a2b96
|
543
|
|
Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness., file e3ad8916-528d-da0e-e053-3705fe0a2b96
|
492
|
|
Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer, file e3ad8916-eedb-da0e-e053-3705fe0a2b96
|
417
|
|
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?, file e3ad891a-3209-da0e-e053-3705fe0a2b96
|
398
|
|
A headlight on liquid biopsies: a challenging tool for breast cancer management, file e3ad8919-1039-da0e-e053-3705fe0a2b96
|
391
|
|
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations, file e3ad8917-5546-da0e-e053-3705fe0a2b96
|
363
|
|
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma, file e3ad8919-b376-da0e-e053-3705fe0a2b96
|
337
|
|
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions, file e3ad8916-f0ee-da0e-e053-3705fe0a2b96
|
334
|
|
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense?, file e3ad8916-d383-da0e-e053-3705fe0a2b96
|
330
|
|
Breast cancer genome-wide association studies: there is strength in numbers, file e3ad891a-50e7-da0e-e053-3705fe0a2b96
|
307
|
|
Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines, file e3ad8916-f0de-da0e-e053-3705fe0a2b96
|
285
|
|
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option?, file e3ad8918-4793-da0e-e053-3705fe0a2b96
|
285
|
|
Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions, file e3ad8923-2872-da0e-e053-3705fe0a2b96
|
285
|
|
Anti-endothelin drugs in solid tumors, file e3ad8917-57be-da0e-e053-3705fe0a2b96
|
279
|
|
Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility?, file e3ad8916-d053-da0e-e053-3705fe0a2b96
|
278
|
|
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer?, file e3ad891a-6317-da0e-e053-3705fe0a2b96
|
250
|
|
The gene expression profile of cumulus cells reveals altered pathways in patients with endometriosis, file e3ad8916-c690-da0e-e053-3705fe0a2b96
|
247
|
|
Type and gene location of kit mutations predict progression-free survival to first-line imatinib in gastrointestinal stromal tumors: A look into the exon, file e3ad8927-2701-da0e-e053-3705fe0a2b96
|
239
|
|
Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma, file e3ad891e-ce83-da0e-e053-3705fe0a2b96
|
216
|
|
Gene signatures in CRC and liver metastasis, file e3ad891c-edc9-da0e-e053-3705fe0a2b96
|
212
|
|
Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway, file e3ad891b-7d86-da0e-e053-3705fe0a2b96
|
202
|
|
The role of Aurora-A inhibitors in cancer therapy., file e3ad8915-e89e-da0e-e053-3705fe0a2b96
|
198
|
|
Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome, file e3ad8927-7bb5-da0e-e053-3705fe0a2b96
|
196
|
|
EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE, file e3ad8917-0bae-da0e-e053-3705fe0a2b96
|
190
|
|
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus, file e3ad8919-b53d-da0e-e053-3705fe0a2b96
|
189
|
|
Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin, file e3ad891b-8a11-da0e-e053-3705fe0a2b96
|
189
|
|
MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness?, file e3ad8916-6fe4-da0e-e053-3705fe0a2b96
|
187
|
|
Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells, file e3ad8916-d6c4-da0e-e053-3705fe0a2b96
|
175
|
|
MicroRNAs in Colorectal Cancer Drug Resistance: Shooters become Targets, file e3ad8916-8c1b-da0e-e053-3705fe0a2b96
|
168
|
|
Primary epithelial ovarian neoplasms: New conceptsconcerning origin, pathogenesis and classification based on morphology, immunomarkers, molecular features, and gene expression studies, file e3ad891c-edcb-da0e-e053-3705fe0a2b96
|
167
|
|
Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer (GIC), file e3ad891d-59d1-da0e-e053-3705fe0a2b96
|
165
|
|
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS?, file e3ad8919-6933-da0e-e053-3705fe0a2b96
|
162
|
|
VUS variants in BRCA genes of hereditary breast/ovarian cancer, file e3ad8915-e9bd-da0e-e053-3705fe0a2b96
|
160
|
|
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC), file e3ad8921-474a-da0e-e053-3705fe0a2b96
|
160
|
|
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients, file e3ad8925-51cb-da0e-e053-3705fe0a2b96
|
159
|
|
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair, file e3ad8916-80e6-da0e-e053-3705fe0a2b96
|
157
|
|
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2, file e3ad8922-ee6c-da0e-e053-3705fe0a2b96
|
136
|
|
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in patients with metastatic melanoma?, file e3ad8920-902b-da0e-e053-3705fe0a2b96
|
117
|
|
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway, file e3ad8919-4bd3-da0e-e053-3705fe0a2b96
|
98
|
|
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge, file e3ad8927-342f-da0e-e053-3705fe0a2b96
|
98
|
|
Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1, file e3ad8921-ef20-da0e-e053-3705fe0a2b96
|
91
|
|
Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and geographic distribution of pathogenic variants in BRCA1/2 genes, file e3ad8922-de27-da0e-e053-3705fe0a2b96
|
90
|
|
A “lymphocyte microrna signature” as predictive biomarker of immunotherapy response and plasma pd-1/pd-l1 expression levels in patients with metastatic renal cell carcinoma: Pointing towards epigenetic reprogramming, file e3ad8925-4d86-da0e-e053-3705fe0a2b96
|
76
|
|
Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer, file 64bedddd-d6ef-44f3-a4a4-cee28b08ca7e
|
61
|
|
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet?, file e3ad891b-5ebe-da0e-e053-3705fe0a2b96
|
57
|
|
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines, file e3ad891b-68c8-da0e-e053-3705fe0a2b96
|
47
|
|
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs), file e3ad8927-33ba-da0e-e053-3705fe0a2b96
|
44
|
|
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay, file 1bd24d10-3d45-4e73-a4c4-698c69ce8bbb
|
33
|
|
Potential agnostic role of BRCA alterations in patients with several solid tumors: One for all, all for one?, file d1cf7fb4-47d2-4a54-8fbe-dad5d1b7858e
|
29
|
|
Prognostic role of plasma pd‐1, pd‐l1, pan‐btn3as and btn3a1 in patients affected by metastatic gastrointestinal stromal tumors: Can immune checkpoints act as a sentinel for short‐term survival?, file e3ad8927-4bd6-da0e-e053-3705fe0a2b96
|
21
|
|
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway, file e3ad8924-a00f-da0e-e053-3705fe0a2b96
|
18
|
|
null, file e3ad891f-7c6c-da0e-e053-3705fe0a2b96
|
16
|
|
Impact of Different Selection Approaches for Identifying Lynch Syndrome-Related Colorectal Cancer Patients: Unity Is Strength, file e3ad8928-8562-da0e-e053-3705fe0a2b96
|
15
|
|
Absence of germline CDKN2A mutation in Sicilian Patients with Familial Malignant Melanoma: could it be a population-specific genetic signature?, file e3ad8918-e599-da0e-e053-3705fe0a2b96
|
11
|
|
HEREDITARY BREAST AND OVARIAN CANCER SYNDROME: FREQUENCY AND DISTRIBUTION OF BRCA1/2 PATHOGENIC VARIANTS IN SICILIAN POPULATION, file e3ad8922-9b7e-da0e-e053-3705fe0a2b96
|
11
|
|
MOLECULAR ANALYSIS OF BRCA1/2 GENES AND MULTIGENE-PANEL TESTING IN SICILIAN TRIPLE NEGATIVE BREAST CANCER, file e3ad8921-5b72-da0e-e053-3705fe0a2b96
|
10
|
|
Spheroids from adipose-derived stem cells exhibit an miRNA profile of highly undifferentiated cells, file e3ad891d-4747-da0e-e053-3705fe0a2b96
|
9
|
|
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls?, file e3ad8919-df5c-da0e-e053-3705fe0a2b96
|
8
|
|
Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer, file 57e6cffe-e52e-4ca7-a5b0-a1795e5fb9f8
|
7
|
|
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in metastatic melanoma patients?, file e3ad891f-7c6d-da0e-e053-3705fe0a2b96
|
6
|
|
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window?, file c0815438-99c9-4c20-bf69-b93a9a81826b
|
5
|
|
Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer, file e3ad891b-8b39-da0e-e053-3705fe0a2b96
|
5
|
|
Liquid Biopsy in Gastrointestinal Stromal Tumor, file e3ad891c-6d78-da0e-e053-3705fe0a2b96
|
5
|
|
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies, file e3ad8916-203c-da0e-e053-3705fe0a2b96
|
4
|
|
Gene expression profiling of cumulus oophorus cells reveals altered pathways in patients with endometriosis, file e3ad8916-f4bd-da0e-e053-3705fe0a2b96
|
3
|
|
Monoclonal antibodies for the treatment of non-hematological tumors: a safety review, file e3ad891e-6582-da0e-e053-3705fe0a2b96
|
2
|
|
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone?, file e3ad8924-cf47-da0e-e053-3705fe0a2b96
|
2
|
|
POLE, POLD1, and NTHL1: the last but not the least hereditary cancer-predisposing genes, file e3ad8927-3724-da0e-e053-3705fe0a2b96
|
2
|
|
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?, file e3ad8928-796d-da0e-e053-3705fe0a2b96
|
2
|
|
BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning, file e3ad8928-8d91-da0e-e053-3705fe0a2b96
|
2
|
|
MUTYH-associated tumor syndrome: The other face of MAP, file e3ad8928-ac05-da0e-e053-3705fe0a2b96
|
2
|
|
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?, file 1341f4f0-38ca-42ed-a965-194a86211815
|
1
|
|
Liquid biopsy and immunotherapy: is all that glitter gold?, file dddf9512-16ff-4f64-b0d5-12af155d0cd9
|
1
|
|
Circular RNA in Exosomes, file e3ad891d-5e0e-da0e-e053-3705fe0a2b96
|
1
|
|
Analysis of Ki-Ras mutations in stage I rectal carcinomas and respective regional lymph nodes., file e3ad891e-2600-da0e-e053-3705fe0a2b96
|
1
|
|
Potential miRNAs involved in molecular pathways mediating the anticancer effects of short term starvation in breast cancer cells treated with doxorubicin, file e3ad8921-f78a-da0e-e053-3705fe0a2b96
|
1
|
|
Challenges and advances for the treatment of renal cancer patients with brain metastases: From immunological background to upcoming clinical evidence on immune-checkpoint inhibitors, file e3ad8927-05b6-da0e-e053-3705fe0a2b96
|
1
|
|
Role of the HIPPO pathway as potential key player in the cross talk between oncology and cardiology, file e3ad8927-add5-da0e-e053-3705fe0a2b96
|
1
|
| Totale |
15.190 |